Close

Now Playing:

French pharmaceutical drug giant Sanofi-Aventis says it wants to buy the U.S. drug company Genzyme for more than $18 billion. The French are turning up the pressure for the deal, after the Americans rejected a smaller offer earlier this summer. Kyle James reports from Berlin.